Obesity White Papers & Case Studies
-
Trial Rescue And Reconnaissance
4/15/2026
Explore a strategic partnership that resulted in a rescue plan for a Phase III oncology trial that was facing high site decline rates.
-
Pharma R&D Annual Review Supplement: New Active Substances
4/15/2026
Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.
-
Futureproofing Post-Approval Compliance
4/15/2026
In the post-approval stage, a synergistic operating model brings PV and regulatory functions under one umbrella: a single governance structure with shared decision cycles, templates, and evidence.
-
Develop Site-Centric Protocols To Optimize Enrollment
4/10/2026
Optimize clinical trial protocols by aligning scientific goals with real-world site operations. Improve enrollment, reduce site burden, and minimize costly amendments through data-driven design.
-
Streamline Data Capture And Automate EHR-To-EDC Data Transfer
4/9/2026
Streamline clinical trials by automating data transfer from EHRs to EDCs. Reduce site burden, minimize manual entry errors, and accelerate timelines to get critical insights faster.
-
Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle
4/9/2026
Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
-
Enhance Clinical Trial Screening And Improve Patient Matching Accuracy
4/9/2026
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
The Definitive Infrastructure For Modern Drug Development
4/9/2026
Modernize clinical trials with AI-powered recruitment and automated EHR data capture to accelerate enrollment, improve data quality, and expand patient access across a global research network.
-
GA Screening: Early Detection For Future Trial Recruitment
4/9/2026
Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.
-
What Re-Acquisition In Retinal Imaging Is Really Costing Your Program
4/6/2026
High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.